{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:02Z","timestamp":1787022182942,"version":"build-2736575974"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>With the global increase in obesity rates and lifestyle changes, metabolic dysfunction-associated steatotic liver disease (MASLD) has become a prevalent chronic liver disorder, affecting approximately 25% of the global population. This disease can progress to cirrhosis and liver cancer, posing a significant threat to public health. To facilitate early diagnosis and intervention, this study aims to develop an efficient and reliable prediction model for MASLD using machine learning algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 9,232 participants aged 20 years and older from the 2017\u20132020 National Health and Nutrition Examination Survey (NHANES). After excluding individuals with frequent alcohol consumption, hepatitis B\/C infection, those lacking liver ultrasound examinations, and samples with missing data, a total of 2,460 subjects were ultimately included. The dataset was split into training and testing sets in an 80:20 ratio. Five machine learning algorithms\u2014XGBoost, Random Forest (RF), and Logistic Regression (LR), among others\u2014were utilized to build prediction models, while Recursive Feature Elimination (RFE) was employed to identify key predictive factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comparison of the five algorithms revealed that the XGBoost algorithm performed the best. Twelve key features were selected through Recursive Feature Elimination (RFE), and the model achieved an AUC of 0.8740 on the testing set, demonstrating excellent predictive accuracy and discriminative ability. SHAP plot analysis of the model showed that waist circumference, BMI, and other factors played a pivotal role in the prediction of MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prediction model developed using the XGBoost algorithm and the 12 selected features demonstrates high efficiency and stability in assessing MASLD risk. This model offers innovative technical solutions and data-driven support for the clinical early identification of high-risk populations, with the potential to optimize and refine MASLD prevention and control strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0335656","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:28:46Z","timestamp":1762972126000},"page":"e0335656","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Machine learning-based prediction of metabolic dysfunction-associated steatotic liver disease using National Health and Nutrition Examination Survey (NHANES) data"],"prefix":"10.1371","volume":"20","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"6","key":"pone.0335656.ref001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.16367","article-title":"Projected Trends in Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality Through 2040","volume":"8","author":"X Zhang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0335656.ref002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"S Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"pone.0335656.ref003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbcan.2018.11.005","article-title":"Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans","volume":"1871","author":"K Chen","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"pone.0335656.ref004","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"TG Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0335656.ref005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"ME Rinella","year":"2023","journal-title":"Hepatology"},{"key":"pone.0335656.ref006","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","article-title":"Fatty Liver Disease: Diagnosis and Stratification","volume":"73","author":"Y Saiman","year":"2022","journal-title":"Annu Rev Med"},{"issue":"6","key":"pone.0335656.ref007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: Mechanisms, Treatments, and Biomarkers","volume":"12","author":"F Nassir","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"pone.0335656.ref008","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"AC Sheka","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"pone.0335656.ref009","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"M Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10464","key":"pone.0335656.ref010","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"M Israelsen","year":"2024","journal-title":"Lancet"},{"key":"pone.0335656.ref011","doi-asserted-by":"crossref","first-page":"1077111","DOI":"10.3389\/fmicb.2022.1077111","article-title":"Graph neural network and multi-data heterogeneous networks for microbe-disease prediction","volume":"13","author":"H Gong","year":"2022","journal-title":"Front Microbiol"},{"key":"pone.0335656.ref012","doi-asserted-by":"crossref","first-page":"1213711","DOI":"10.3389\/fendo.2023.1213711","article-title":"Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks","volume":"14","author":"X Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"pone.0335656.ref013","doi-asserted-by":"crossref","first-page":"100384","DOI":"10.1016\/j.advnut.2025.100384","article-title":"Perspective: Global Burden of Iodine Deficiency: Insights and Projections to 2050 Using XGBoost and SHAP","volume":"16","author":"D Liang","year":"2025","journal-title":"Adv Nutr"},{"issue":"2","key":"pone.0335656.ref014","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.32655","article-title":"Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis","volume":"77","author":"D Chang","year":"2023","journal-title":"Hepatology"},{"key":"pone.0335656.ref015","doi-asserted-by":"crossref","first-page":"1544084","DOI":"10.3389\/fnut.2025.1544084","article-title":"The relationship between visceral adiposity index and estimated pulse wave velocity: insights from NHANES database","volume":"12","author":"Y Liu","year":"2025","journal-title":"Front Nutr"},{"issue":"8","key":"pone.0335656.ref016","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/s25082388","article-title":"Ensemble Machine Learning Models Utilizing a Hybrid Recursive Feature Elimination (RFE) Technique for Detecting GPS Spoofing Attacks Against Unmanned Aerial Vehicles","volume":"25","author":"R Al-Syouf","year":"2025","journal-title":"Sensors (Basel)"},{"issue":"168","key":"pone.0335656.ref017","first-page":"1","article-title":"National Health and Nutrition Examination Survey: National Youth Fitness Survey Estimation Procedures, 2012","author":"CL Johnson","year":"2014","journal-title":"Vital and Health Statistics Series 2, Data Evaluation and Methods Research"},{"key":"pone.0335656.ref018","doi-asserted-by":"crossref","first-page":"20552076241272535","DOI":"10.1177\/20552076241272535","article-title":"Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020","volume":"10","author":"L Liu","year":"2024","journal-title":"Digit Health"},{"key":"pone.0335656.ref019","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.2147\/JIR.S471626","article-title":"Interpretable Machine Learning Model for Predicting the Prognosis of Guillain-Barr\u00e9 Syndrome Patients","volume":"17","author":"J Guo","year":"2024","journal-title":"J Inflamm Res"},{"issue":"10","key":"pone.0335656.ref020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","article-title":"Logistic regression: a brief primer","volume":"18","author":"JC Stoltzfus","year":"2011","journal-title":"Acad Emerg Med"},{"issue":"2","key":"pone.0335656.ref021","article-title":"A review on longitudinal data analysis with random forest","volume":"24","author":"J Hu","year":"2023","journal-title":"Brief Bioinform"},{"issue":"6","key":"pone.0335656.ref022","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1007\/s10278-024-01172-0","article-title":"LightGBM is an Effective Predictive Model for Postoperative Complications in Gastric Cancer: A Study Integrating Radiomics with Ensemble Learning","volume":"37","author":"W Wang","year":"2024","journal-title":"J Imaging Inform Med"},{"issue":"1","key":"pone.0335656.ref023","doi-asserted-by":"crossref","first-page":"24851","DOI":"10.1038\/s41598-024-72663-x","article-title":"Optimization of SVR and CatBoost models using metaheuristic algorithms to assess landslide susceptibility","volume":"14","author":"RS Ajin","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0335656.ref024","doi-asserted-by":"crossref","first-page":"874455","DOI":"10.3389\/fpubh.2022.874455","article-title":"An Explainable AI Approach for the Rapid Diagnosis of COVID-19 Using Ensemble Learning Algorithms","volume":"10","author":"H Gong","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0335656.ref025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","article-title":"Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Q Chen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0335656.ref026","doi-asserted-by":"crossref","first-page":"155642","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"P Golabi","year":"2023","journal-title":"Metabolism"},{"issue":"2","key":"pone.0335656.ref027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/gutjnl-2022-327498","article-title":"Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis","volume":"72","author":"G Angelini","year":"2023","journal-title":"Gut"},{"key":"pone.0335656.ref028","doi-asserted-by":"crossref","first-page":"155931","DOI":"10.1016\/j.metabol.2024.155931","article-title":"DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases","volume":"159","author":"Y Handelsman","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"pone.0335656.ref029","doi-asserted-by":"crossref","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"R Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"pone.0335656.ref030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ajg.2014.134","article-title":"Nonalcoholic fatty liver disease is underrecognized in the primary care setting","volume":"110","author":"P Blais","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"pone.0335656.ref031","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD","volume":"13","author":"F Abdelhameed","year":"2024","journal-title":"Curr Obes Rep"},{"issue":"2","key":"pone.0335656.ref032","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"R Paternostro","year":"2022","journal-title":"J Intern Med"},{"key":"pone.0335656.ref033","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/liv.13653","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: why liver biopsy is essential","volume":"38","author":"P Bedossa","year":"2018","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:28:52Z","timestamp":1762972132000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335656"}},"subtitle":[],"editor":[{"given":"Aleksandra","family":"Klisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335656","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}